Archives

by in
Entry Author Date Location
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer 02/25/11 Boston
Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News 02/25/11 San Francisco
Genentech Gets FDA Hearing 02/24/11 San Francisco
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News 02/18/11 Boston
Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result 02/16/11 Boston
Genomic Health, Taking a Hit on Bottom Line, Bets Next-Gen Sequencing Will Yield Next-Gen Diagnostics 02/15/11 San Francisco
Hologic Gets FDA Nod for 3-D Mammography 02/14/11 Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
NanoString, Snapping Up Genomic Health Veteran, Seeks to Prove Economic Value of Cancer Diagnostic 02/03/11 Seattle
FDA To Yank Avastin Breast Cancer Approval 12/16/10 San Francisco
Genomic Health Seeks to Build Momentum For Healthcare Shift from Rx to Dx 11/08/10 San Francisco
PacBio IPO, Not Exactly the Netscape Moment of 2010, But a Win for Genomics 10/28/10 San Francisco
Genentech’s Souped-Up Breast Cancer Drug Beats Original Herceptin in Head-to-Head Study 10/08/10 San Francisco
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs 09/07/10 Boston
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA 08/27/10 Boston
Biocept Targets Spreading Tumors With Advance in Diagnostics 08/20/10 San Diego
Syndax Pharma Snags $6M Debt Deal 08/09/10 Boston
Genentech Fails to Sway FDA Panel 07/20/10 San Francisco
Corey Goodman’s New Startup, UCSF Spinoff Raises $40M, Gail Maderis Gives Back, & More Bay Area Life Sciences News 07/09/10 San Francisco
Genentech Seeks FDA Nod for T-DM1 07/07/10 San Francisco
On-Q-ity, Led by Former Genzyme Exec, Takes on “Diagnostic Black Hole” in Cancer 07/07/10 Boston
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build Pipeline 06/28/10 Boston
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
Syndax’s Breast Cancer Drug Advances, Arena Raises Equity Financing, BeneChill Recruits a CEO, & More San Diego Life Sciences News 06/10/10 San Diego
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer 06/08/10 Boston
All-Michigan VC Team Helps Bring State-Grown Medical Imaging Technology to Market 06/03/10 Detroit
Detroit Breast Cancer Imaging Company Delphinus Medical Gets $8M Investment 05/25/10 Detroit
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.